bioRxiv ScienceSearch

bioRxiv · 10.1101/800888

Age of seizure onset as a major determinant of memory changes following surgery for hippocampal sclerosis

Abstract

ObjectiveTo study the relation of epileptological and surgical variables with post-operative memory performance, following surgery for refractory mesial temporal lobe epilepsy (MTLE) due to hippocampal sclerosis (HS).\n\nMethodsLogical memory (LM) and visual memory (VM) scores for immediate and late recall of 201 patients operated for MTLE/HS from 1996 to 2016 were reviewed. All patients were evaluated prior to surgery and reevaluated up until 5 years after the procedure. Scores were standardized to a control group of 54 healthy individuals matched for age and education. Patients were divided in two groups according to the hemisphere affected and scores for immediate and late recall were compared. Reliable Change Index (RCI) with a 90% confidence interval was performed to verify individual memory changes for each late LM (lLM) and late VM (lVM) score. A multiple linear regression was performed with the RCI using late recall scores of lLM and lVM and clinical variables.\n\nResults112 (56%) patients had left HS (lHS). The lHS group showed decreased immediate LM (iLM) scores before and after surgery (p<0.05), compared with rHS. The rHS group showed increased iLM scores post-operatively (p<0.05). RCI of the rHS group showed that 6 (7%) individuals had improved, 78 (87%) stabilized and 5 (6%) decresead in lLM scores, and for lVM 7 (8%) improved, 80 (89%) stabilized and 2 (3%) worsened (RCI> 1.645). RCI of the lHS group showed that 3 (3%) individuals had increased scores, 104 (93%) stabilized and 5 (4%) worsened for lLM, and for lVM 3 (3%) obtained improved scores, 103 (92%) stabilized and 6 (5%) decreased (RCI> 1.645). lHS and later age of onset of the first epileptic seizure were predictors of lLM loss (p<0.05).\n\nConclusionLeft MTLE/HS and later age of seizure onset were predictive factors for worsening of lLM. No RCI predictors of post-op lVM performance were identified. We found a decreased baseline functioning of LM in the lHS group and improvement of LM in some patients who had resection of the right MTL. Patients of the rHS group had a higher percentage of reliable post-op improvement for both VM and LM scores.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Leal-Conceicao, E., Bianchin, M., Vendramini Borelli, W., Januario de Oliveira, L., Palmini, A., Radaelli, G., Wagner, M., Paglioli, E., Spencer Escobar, V., Dacosta, J., Wetters Portuguez, M.. 2019-10-10. Age of seizure onset as a major determinant of memory changes following surgery for hippocampal sclerosis. https://doi.org/10.1101/800888

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience